Lazard Asset Management’s Ascendis Pharma ASND Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.08M | Buy |
52,628
+9,505
| +22% | +$1.64M | 0.01% | 570 |
|
2025
Q1 | $6.72M | Buy |
+43,123
| New | +$6.72M | 0.01% | 594 |
|
2021
Q4 | – | Sell |
-6,712
| Closed | -$1.07M | – | 2281 |
|
2021
Q3 | $1.07M | Buy |
+6,712
| New | +$1.07M | ﹤0.01% | 1054 |
|
2016
Q2 | – | Sell |
-193,050
| Closed | -$3.58M | – | 1043 |
|
2016
Q1 | $3.58M | Hold |
193,050
| – | – | 0.01% | 537 |
|
2015
Q4 | $3.54M | Sell |
193,050
-17,275
| -8% | -$316K | 0.01% | 563 |
|
2015
Q3 | $3.72M | Hold |
210,325
| – | – | 0.01% | 527 |
|
2015
Q2 | $3.7M | Buy |
210,325
+5,500
| +3% | +$96.7K | 0.01% | 569 |
|
2015
Q1 | $3.55M | Buy |
+204,825
| New | +$3.55M | 0.01% | 577 |
|